| RS2136132894 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136134076 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136136946 |
IPO8
|
Health Risk |
Likely pathogenic |
IPO8 related Connective tissue disorder, VISS syndrome |
| RS2136138396 |
MDM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Accelerated tumor formation, susceptibility to |
| RS2136138688 |
RDH5
|
Health Risk |
Pathogenic |
— |
| RS2136139535 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2136139920 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2136141104 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136141530 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136142116 |
RDH5
|
Health Risk |
Pathogenic |
Pigmentary retinal dystrophy, Pigmentary retinal dystrophy |
| RS2136142315 |
RDH5
|
Health Risk |
Pathogenic |
— |
| RS2136142487 |
MEN1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2136143369 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS2136144177 |
IPO8
|
Health Risk |
Likely pathogenic |
VISS syndrome, VISS syndrome |
| RS2136148225 |
MEN1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2136148702 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136148788 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136150891 |
IPO8
|
Health Risk |
Pathogenic |
IPO8 related Connective tissue disorder, IPO8 related Connective tissue disorder |
| RS2136151586 |
PEX5
|
Health Risk |
Pathogenic/Likely pathogenic |
Abnormality of metabolism/homeostasis, Peroxisome biogenesis disorder 2B |
| RS2136151708 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2136152576 |
IPO8
|
Health Risk |
Pathogenic |
IPO8-related aortopathy, VISS syndrome |
| RS2136153237 |
MAPKAPK5
|
Health Risk |
Pathogenic |
Neurocardiofaciodigital syndrome, Neurocardiofaciodigital syndrome |
| RS2136153753 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136154117 |
HPS1
|
Health Risk |
Pathogenic |
— |
| RS2136154163 |
MEN1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2136154449 |
HPS1
|
Health Risk |
Likely pathogenic |
— |
| RS2136154587 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136154828 |
MEN1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2136156268 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136156603 |
HPS1
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome with pulmonary fibrosis, Hermansky-Pudlak syndrome with pulmonary fibrosis |
| RS2136156789 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS2136158237 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136158689 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2136158725 |
ATP2B1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Intellectual developmental disorder |
| RS2136158926 |
IPO8
|
Health Risk |
Pathogenic |
IPO8-related aortopathy, IPO8-related aortopathy |
| RS2136159431 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS2136163112 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2136163711 |
IPO8
|
Health Risk |
Pathogenic |
IPO8-related aortopathy, IPO8-related aortopathy |
| RS2136163716 |
IPO8
|
Health Risk |
Pathogenic |
IPO8-related aortopathy, VISS syndrome |
| RS2136164671 |
MIP
|
Health Risk |
Likely pathogenic |
— |
| RS2136164699 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136165507 |
IPO8
|
Health Risk |
Pathogenic |
IPO8 related Connective tissue disorder, IPO8 related Connective tissue disorder |
| RS2136166539 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136167830 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136167939 |
ATM
|
Health Risk |
Pathogenic |
— |
| RS2136169465 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136170176 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136171586 |
TCTN1
|
Health Risk |
Pathogenic |
Joubert syndrome 13, Joubert syndrome |
| RS2136172776 |
TCTN1
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2136176386 |
PEX5
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2136176644 |
DENND5A
|
Health Risk |
Pathogenic |
— |
| RS2136178004 |
MEN1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS2136178143 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136181049 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136184555 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136186060 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136186754 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136187018 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136187161 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136188216 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136188431 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136189816 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136192267 |
ATP2B1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Intellectual developmental disorder |
| RS2136192590 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136192612 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136192730 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136192749 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS2136192884 |
HPS1
|
Health Risk |
Pathogenic |
— |
| RS2136193574 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136193860 |
ATP2B1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Intellectual developmental disorder |
| RS2136194342 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136194414 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS2136195113 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136195903 |
TCTN1
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2136197089 |
HPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 1, Hermansky-Pudlak syndrome 1 |
| RS2136197117 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS2136198139 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136198351 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136198361 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136198918 |
GRIA4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without seizures and gait abnormalities, See cases |
| RS2136199221 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136199270 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136199292 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136199436 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136199734 |
MMAB
|
Health Risk |
Likely pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136203174 |
CHD4
|
Health Risk |
Likely pathogenic |
— |
| RS2136203848 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136203888 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136205876 |
HPS1
|
Health Risk |
Likely pathogenic |
— |
| RS2136208238 |
TENM4
|
Health Risk |
Pathogenic |
Tremor, hereditary essential |
| RS2136208377 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136209158 |
CHD4
|
Health Risk |
Pathogenic/Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Inborn genetic diseases |
| RS2136209181 |
CHD4
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2136209186 |
CHD4
|
Health Risk |
Pathogenic/Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS2136209729 |
CHD4
|
Health Risk |
Pathogenic |
— |
| RS2136211819 |
ST14
|
Health Risk |
Likely pathogenic |
Autosomal recessive congenital ichthyosis 11, Autosomal recessive congenital ichthyosis 11 |
| RS2136211948 |
SYT1
|
Health Risk |
Likely pathogenic |
— |
| RS2136212739 |
HPS1
|
Health Risk |
Pathogenic |
— |
| RS2136213384 |
CHD4
|
Health Risk |
Pathogenic/Likely pathogenic |
CHD4-related disorder, CHD4-related disorder |
| RS2136213423 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |